Famotidine Prices, Trend 2026: Index, Demand, Chart and Forecast

According to ChemAnalyst, The Famotidine Prices recorded a largely stable to moderately firm performance during the second quarter of 2026, with regional prices influenced primarily by logistics, freight, insurance, and landed-cost adjustments. Famotidine is an important histamine H2-receptor antagonist widely used in pharmaceutical formulations for the management of acid-related gastrointestinal conditions. Because the product is closely linked to pharmaceutical manufacturing and healthcare procurement, its pricing dynamics are shaped not only by raw-material and production costs but also by international transportation and supply-chain conditions.

During Q2 2026, the global Famotidine market showed relatively limited price movement compared with more volatile pharmaceutical ingredients. North America and APAC recorded a 1.75% quarter-over-quarter increase in the Famotidine Price Index, while the European market remained broadly stable. The increase was primarily attributed to higher freight-related expenses and associated insurance costs rather than a significant change in underlying demand.

In the United States, the average Famotidine price reached approximately USD 58,549.33/MT, while China's average price was approximately USD 58,402.67/MT. Germany experienced comparatively stable market conditions, with predictable import flows and steady procurement from OTC and hospital channels helping to limit price fluctuations.

Famotidine Prices in North America

The North American Famotidine market experienced a modest upward movement during Q2 2026. In the United States, the Famotidine Price Index increased by 1.75% quarter-over-quarter, primarily because of recent increases in freight costs.

The average Famotidine price in the USA stood at approximately USD 58,549.33/MT during the quarter. The increase was relatively small, indicating that the market remained fundamentally balanced. Instead of being driven by a substantial supply shortage or a sharp increase in pharmaceutical demand, the upward movement was largely associated with higher landed costs.

Freight represents an important component of the delivered cost of pharmaceutical ingredients, particularly when active pharmaceutical ingredients (APIs) and intermediates are sourced internationally. Changes in ocean freight rates, insurance premiums, port-related expenses, and transportation availability can therefore affect the final price paid by pharmaceutical manufacturers and distributors.

During the quarter, the U.S. market continued to benefit from relatively predictable pharmaceutical procurement. Demand from OTC and prescription-related pharmaceutical applications remained supportive, while supply availability prevented a stronger price escalation.

The modest increase in Famotidine Prices therefore indicates a market characterized by cost pass-through rather than fundamental demand-driven inflation. Buyers continued to monitor logistics costs closely, particularly for imported material, as transportation expenses became an increasingly visible component of delivered API pricing.

Get Real Time Online for Famotidine Prices: https://www.chemanalyst.com/Pricing-data/famotidine-2540

Famotidine Prices in APAC

The APAC market followed a trend similar to North America during Q2 2026. In China, the Famotidine Price Index increased by 1.75% quarter-over-quarter, with higher freight insurance costs serving as a major contributor to the increase.

The average Famotidine price in China was approximately USD 58,402.67/MT during the quarter. The relatively close pricing between China and the United States highlights the importance of freight and landed-cost considerations in international Famotidine trade.

China remains an important pharmaceutical manufacturing and API supply hub, making its Famotidine market particularly relevant to global buyers. Changes in export logistics, shipping costs, insurance premiums, and delivery schedules can influence the effective price available to overseas pharmaceutical manufacturers.

During Q2 2026, the increase in Chinese Famotidine prices was not associated with a major structural tightening of supply. Instead, the market experienced freight cost pass-through, whereby higher logistics expenses were reflected in quoted and delivered prices.

The APAC pharmaceutical supply chain also continued to emphasize cost efficiency and inventory management. Manufacturers and distributors remained attentive to procurement timing, shipment consolidation, and inventory levels as ways of controlling exposure to transportation-related price changes.

The modest 1.75% increase consequently suggests that the underlying Famotidine market remained relatively balanced, while external logistics factors created incremental upward pressure.

Famotidine Prices in Europe

The European Famotidine market remained comparatively stable during Q2 2026. Germany's Famotidine Price Index was broadly unchanged quarter-over-quarter, supported by predictable import flows and steady procurement from OTC and hospital pharmaceutical channels.

Germany represents an important pharmaceutical market in Europe, and consistent purchasing patterns helped create a relatively stable pricing environment. Pharmaceutical manufacturers, distributors, hospitals, and OTC suppliers maintained regular procurement requirements, limiting the potential for significant price volatility.

Although freight normalization and modest insurance adjustments created some marginal pressure on landed costs, these factors were not sufficient to produce a significant change in the overall Famotidine price level.

The European market therefore differed slightly from the United States and China, where the Price Index recorded a measurable 1.75% increase. In Germany, stable supply availability and predictable import schedules helped absorb some of the logistics-related cost pressure.

For European buyers, this stability provides greater visibility for procurement planning. However, continued monitoring of international freight rates remains important because Europe relies significantly on global pharmaceutical supply chains.

Key Factors Influencing Famotidine Prices in Q2 2026

Several factors influenced the global Famotidine market during the quarter.

Freight Costs

Freight was one of the most important factors behind the increase in Famotidine Prices in the United States and China. Higher transportation costs increased the delivered price of imported material, particularly where suppliers passed these expenses through to buyers.

Insurance Costs

Higher freight insurance costs also contributed to the increase observed in China. Insurance forms part of the landed cost of internationally traded pharmaceutical ingredients, and changes in risk premiums can influence final transaction prices.

Pharmaceutical Demand

Demand remained relatively stable during Q2 2026. Famotidine continues to have established applications in pharmaceutical formulations, supporting recurring procurement requirements. However, the absence of a major demand surge limited the possibility of a sharp price increase.

Import Flows

Predictable import flows were particularly important in Germany. Stable shipments helped maintain supply availability and prevented logistics disruptions from translating into significant price increases.

OTC and Hospital Procurement

Steady procurement from OTC and hospital channels provided an underlying demand floor. Regular pharmaceutical purchasing helped keep the market balanced even as transportation costs changed.

Landed-Cost Adjustments

The Q2 2026 market demonstrates that Famotidine pricing cannot be assessed solely through producer-level manufacturing costs. Freight, insurance, port charges, and other logistics expenses can materially influence the final delivered price.

Global Famotidine Price Comparison

Region	Market	Q2 2026 Price Index Movement	Average Price	Primary Driver
North America	USA	+1.75% QoQ	USD 58,549.33/MT	Higher freight costs
APAC	China	+1.75% QoQ	USD 58,402.67/MT	Freight insurance costs
Europe	Germany	Broadly stable	Marginal landed-cost pressure	Predictable imports and steady procurement

The regional comparison shows that the global Famotidine market remained relatively stable in Q2 2026. The United States and China registered identical quarter-over-quarter growth of 1.75%, while Germany recorded a broadly stable price environment.

Famotidine Supply Chain and Procurement Trends

The Famotidine supply chain remained focused on maintaining consistent pharmaceutical-grade availability while managing logistics expenditure. Pharmaceutical companies typically prioritize reliability and quality alongside price when procuring APIs, making supply continuity an important consideration.

During Q2 2026, buyers faced a relatively manageable pricing environment. The limited price increase in North America and APAC suggests that suppliers were able to maintain regular availability, while additional logistics expenses were incorporated into final quotations.

Procurement strategies consequently remained centered on shipment planning, supplier diversification, inventory optimization, and monitoring of freight conditions. Buyers with longer procurement horizons may benefit from closely tracking transportation costs because even moderate increases can affect the landed cost of high-value pharmaceutical ingredients.

The relatively stable European market also demonstrates the importance of efficient import networks. Predictable shipment schedules can help offset some of the cost volatility associated with international logistics.

Book A Demo for Famotidine Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Famotidine

Production Cost Perspective

Production costs remain an important long-term consideration for Famotidine Prices. Although Q2 2026 price movements were primarily associated with freight and insurance, manufacturers continue to monitor costs associated with pharmaceutical-grade raw materials, utilities, labor, quality control, regulatory compliance, packaging, and facility operations.

Pharmaceutical APIs require stringent quality standards and controlled production environments. Consequently, changes in compliance requirements, manufacturing expenses, energy costs, or raw-material availability can eventually influence market pricing.

However, the relatively modest movement recorded during Q2 2026 indicates that these production-side factors did not create significant additional pressure during the quarter. Instead, transportation-related expenses were more prominent in determining regional price changes.

Famotidine Market Outlook

Looking ahead, the Famotidine Prices outlook will depend on the interaction between pharmaceutical demand, manufacturing costs, supply availability, and global logistics.

If freight markets remain stable, Famotidine prices could continue to experience relatively limited fluctuations. The established nature of pharmaceutical demand should provide a degree of market support, while predictable supply availability could prevent substantial upward movements.

However, renewed increases in international freight rates or insurance premiums could place additional pressure on landed costs. This would be particularly relevant for import-dependent markets and buyers operating with limited inventory buffers.

The European market may continue to show comparatively stable pricing if import flows remain predictable and pharmaceutical procurement stays consistent. Meanwhile, North American and Asian buyers are likely to remain sensitive to transportation costs because these expenses directly influence delivered API prices.

From a procurement perspective, monitoring freight trends alongside supplier quotations will remain essential. Companies that evaluate only the base product price may overlook changes in total landed cost.

Conclusion

The Famotidine Prices market remained relatively stable but recorded modest upward pressure during Q2 2026. In the United States, the Famotidine Price Index increased 1.75% quarter-over-quarter, with the average price reaching approximately USD 58,549.33/MT. The increase was mainly linked to higher freight costs and marginal landed-cost pressure.

China followed the same 1.75% quarter-over-quarter increase, with the average Famotidine price reaching approximately USD 58,402.67/MT. Higher freight insurance costs and their subsequent pass-through into delivered prices were the primary factors behind the increase.

Germany presented a different picture, with the Famotidine Price Index remaining broadly stable. Predictable import flows and steady OTC and hospital procurement helped maintain market balance, while freight normalization and modest insurance adjustments generated only marginal landed-cost pressure.

Overall, Q2 2026 demonstrated that the Famotidine market remained fundamentally balanced. The modest regional price increases were driven more by logistics than by significant changes in supply-demand fundamentals. Going forward, freight conditions, insurance costs, pharmaceutical procurement, import flows, and manufacturing economics will remain the key variables shaping the global Famotidine Price Trend.

 

 

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: sales@chemanalyst.com

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_